- Home
- RES vs NUVB Comparison
RES vs NUVB Comparison
Compare RES & NUVB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RES
- NUVB
- Stock Information
- Founded
- RES 1984
- NUVB 2018
- Country
- RES United States
- NUVB United States
- Employees
- RES N/A
- NUVB N/A
- Industry
- RES Oilfield Services/Equipment
- NUVB Biotechnology: Pharmaceutical Preparations
- Sector
- RES Energy
- NUVB Health Care
- Exchange
- RES Nasdaq
- NUVB Nasdaq
- Market Cap
- RES 977.3M
- NUVB 837.0M
- IPO Year
- RES N/A
- NUVB N/A
- Fundamental
- Price
- RES $4.77
- NUVB $2.91
- Analyst Decision
- RES Hold
- NUVB Strong Buy
- Analyst Count
- RES 4
- NUVB 6
- Target Price
- RES $4.69
- NUVB $8.00
- AVG Volume (30 Days)
- RES 1.9M
- NUVB 4.7M
- Earning Date
- RES 07-24-2025
- NUVB 08-07-2025
- Dividend Yield
- RES 3.36%
- NUVB N/A
- EPS Growth
- RES N/A
- NUVB N/A
- EPS
- RES 0.25
- NUVB N/A
- Revenue
- RES $1,426,699,000.00
- NUVB $14,355,000.00
- Revenue This Year
- RES $12.58
- NUVB $332.80
- Revenue Next Year
- RES $6.53
- NUVB $360.12
- P/E Ratio
- RES $19.05
- NUVB N/A
- Revenue Growth
- RES N/A
- NUVB 900.35
- 52 Week Low
- RES $4.10
- NUVB $1.54
- 52 Week High
- RES $7.22
- NUVB $3.46
- Technical
- Relative Strength Index (RSI)
- RES 55.84
- NUVB 66.89
- Support Level
- RES $4.34
- NUVB $2.57
- Resistance Level
- RES $4.50
- NUVB $2.55
- Average True Range (ATR)
- RES 0.16
- NUVB 0.20
- MACD
- RES 0.02
- NUVB 0.03
- Stochastic Oscillator
- RES 94.68
- NUVB 90.62
About RES RPC Inc.
RPC Inc is an oilfield services company. It provides specialized oilfield services and equipment to independent and oil and gas companies engaged in the exploration, production, and development of oil and gas properties throughout the United States. The company's operating segment includes Technical Services and Support Services. It generates maximum revenue from the Technical Services segment. Technical Services segment nclude RPC's oil and gas services that utilize people and equipment to perform value-added completion, production and maintenance services directly to a customer's well. Support Services segment consists of drill pipe and related tools, pipe handling, pipe inspection and storage services, and oilfield training and consulting services.
About NUVB Nuvation Bio Inc.
Nuvation Bio Inc is a biopharmaceutical company tackling unmet needs in oncology by developing differentiated and novel therapeutic candidates. Its product candidate, taletrectinib, is an oral, potent, central nervous system-active, selective, next-generation c-ros oncogene 1 (ROS1) inhibitor specifically designed for the treatment of patients with ROS1+ non-small cell lung cancer (NSCLC). In addition, its clinical-stage pipeline includes differentiated, novel oncology product candidates such as Safusidenib, NUV-1511, and NUV-868 in their different stages of development. The company generates revenue through out-licensing collaborative agreements with its customers located in China and Japan.